Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

The Use of Sphingosine1-Phosphate Receptor (S1pr) Modulators

Silvia Vendetti of Istituto Superiore di Sanità in Italy proposes to improve vaccine immunization by transiently accumulating a high number of antigen-specific precursor cells in the lymph nodes at the time of immunization using agents that modulate cell migration as a new vaccine technology platform.

More information about Explore New Solutions for Global Health Priority Areas (Round 8)